Has chondro-stimulating, regenerating, anti-inflammatory and analgesic effect. Chondroitin sulfate participates in the construction of the main substance of cartilage and bone tissue. Has chondroprotective properties, enhances metabolic processes in hyaline and fibrous cartilage, subchondral bone; inhibits enzymes that cause degeneration (destruction) of articular cartilage; stimulates the production of chondrocytes proteoglycans.Helps reduce the release of synovial fluid mediators of inflammation and pain, suppresses the secretion of leukotrienes and prostaglandins. Slows the resorption of bone tissue and reduces calcium loss, accelerates the recovery of bone tissue.
Chondroitin sulfate slows the progression of osteoarthritis and osteochondrosis. Promotes the restoration of the articular bag and the cartilaginous surfaces of the joints, prevents the collapse of connective tissue, normalizes the production of joint fluid.
When using the drug, soreness decreases and mobility of affected joints improves, while the therapeutic effect persists for a long time after the end of the course of therapy. In the treatment of degenerative joint changes accompanied by a secondary synovitis, the effect is observed after 2-3 weeks from the start of the course.
Having structural similarity with heparin, it can potentially prevent the formation of fibrin clots in the synovial and subchondral microcirculatory bed.